Directory

Full Time Faculty

Jennifer Lim , MD Professor of Ophthalmology Marion Schenk Esq. Chair of Ophthalmology Director, Retina Services Vitreoretinal Service

Specialization
Macular diseases, complex retinal detachments, diabetic retinopathy

Research Interests
Age-related macular degeneration (AMD) and diabetic retinopathy, immunohistochemistry of surgical specimens, anti-angiogenesis treatments, sustained release drug delivery for macular edema, ocular coherence tomography (OCT) and retinal diseases

Clinical Trials

Regeneron
A Randomized, Double Masked, Controlled Phase 3 Study of the Efficacy, Safety, and Tolerability of Repeated Intravitreal Administration of VEGF Trap-Eye in Subjects with Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO). Role: Study Site PI, 01/10- present.

U10 EY014231 NIH/National Eye Institute/ Diabetic Retinopathy Clinical Research Network/Jaeb Center
Evaluation of Visual Acuity Measurements in Eyes with Diabetic Macular Edema (Protocol L)  Role: Study Site PI, 07/09-present.
 
Comparison of Time Domain OCT and Spectral Domain OCT Retinal Thickness Measurement in Diabetic Macular Edema (Protocol O). Role: Study Site PI, 07/09-present.

An Observational Study in Individuals with Diabetic Retinopathy without Center-Involved DME Undergoing Cataract Surgery (Protocol Q). Role: Study Site PI, 07/09-present.
 
Intravitreal Ranibizumab or Triamcinolone Acetonide as Adjunctive Treatment to Pan Retinal Photocoagulation for Proliferative Diabetic Retinopathy (Protocol J) Role: Study Site PI, 6/08-present.
 
Intravitreal Ranibizumab or Triamcinolone Acetonide in Combination with Laser Photocoagulation for Diabetic Macular Edema (Protocol I). Role  Study Site PI 6/08-present.  

ICON Bioscience
An Open-Label Study of the Safety and Tolerability of Combining 20089 (Triamcinolone Acetonide Intravitreal Injection) When Used Adjunctively with Lucentis® 0.5 mg Intravitreal Injection in Subjects with Subfoveal Neovascular Age-Related Macular Degeneration (ICON Combo). Role: Study Site PI, 07/09-present.

Gerhard Cless Family Endowment (Investigator Initiated)
Optical Coherence Tomographical Retinal Thickness Analysis of Sickle Cell Patients. Role: PI, 12/08- present.

ICON Bioscience
An Open-Label, Dose Escalation Study of the Safety and Tolerability of 20089 (Triamcinolone Acetonide Intravitreal Injection) in the Treatment of Patients with Cystoid Macular Edema Associated with Retinal Vein Occlusion or Cataract Surgery. Role: Study Site PI, 01/08-8/09.
 
Investigator Initiated: An Experimental Approach to Maculopathy. Role: PI, 12/07-present

Education

UIC Appointments
July 2007: Professor of Ophthalmology, University of Illinois at Chicago Eye and Ear Infirmary

Recent Publications
Peer Reviewed

Dinc UA, Yenerel NM, Gorun E, Yetik H, Kokame GT, Lim JI. Diagnostic and therapeutic challenges. Retina. 2009; 29:275-9.

Nguyen QD, Shah SM, Heier J, Do DV, Lim JI, Boyer D, Abraham P, Campochiaro PA, for the READ-2 Study Group. VEGF Blockade in Diabetic Macular Edema: Primary Endpoint (6 Months) Results of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study.  Ophthalmology. 2009; 116:2175-81.

Bhavsar AR, Googe Jr JM, Bressler NM,  Brucker AJ, Elman MJ, Glassman AR, Stockdale CR, for the Diabetic Retinopathy Clinical Research Network.  The Risk of Endophthalmitis Following Intravitreal Injection in the DRCR.net Laser-Ranibizumab-Triamcinolone Clinical Trials. Arch Ophthalmol. 2009; 127:1581-83.

Kaiser PK, for the Visudyne in Occult CNV (VIO) Study Group. Verteporfin therapy of subfoveal occult with no classic choroidal neovascularization in age-related macular degeneration: Two-Year Results of a Randomized Clinical Trial. (Writing Committee Member). Curr Med Res Opin. 2009;25:1853-60.
 
Friberg TR, Brennen PM, Freeman WR, Musch DC; PTAMD Study Group. Prophylactic treatment of age-related macular degeneration report number 2: 810-nanometer laser to eyes with drusen: bilaterally eligible patients. Ophthalmic Surg Lasers Imaging. 2009 Nov-Dec;40(6):530-8.
 
Diabetic Retinopathy Clinical Research Network, Elman MJ, Aiello LP, Beck RW, Bressler NM, Bressler SB, Edwards AR, Ferris FL 3rd, Friedman SM, Glassman AR, Miller KM, Scott IU, Stockdale CR, Sun JK. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology. 2010;117:1064-1077.
 
Lim JI, Spee C, Hinton D. A comparison of HIF-1a in surgically excised regressed neovascular membranes of diabetic patients and epiretinal membranes in non-diabetic patients. Retina. 2010 Oct;30(9):1472-1478.
 
Vasconcelos-Santos DV, Lim JI, Rao NA. Chronic cocciodioidomycosis endophthalmitis without concomitant systemic involvement: a clinicopathological case report. Ophthalmology 2010;117:1839-1842.
 
Nguyen QD, Shah SM, Khwaja AA, Channa R, Hatef E, Do DV, Boyer D, Heier JS, Abraham P, Thach AB, Lit ES, Foster BS, Kruger E, Dugel P, Chang T, Das A, Ciulla TA, Pollack JS, Lim JI, Eliot D, Campochiaro PA; READ-2 Study Group. Two year outcomes of the ranibizumab for edema of the macula in diabetes (READ-2) study. Ophthalmology. 2010 Nov;117(11):2146-2151.
 
Hoang QV, Chau F, Shahidi M, Lim JI. Central macular splaying and outer retinal thinning in asymptomatic sickle cell patients by optical coherence tomography. Am J Ophthalmol; 2010. in press.

Lim JI, Fung AE, Wieland M, Hung D, Wong V. Sustained release intravitreal liquid drug delivery using triamcinolone acetonide for cystoid macular edema in retinal vein occlusion. Ophthalmology; 2010: in press

Non Peer Reviewed

Galasso J, Lim JI. The Hidden Cost of Avastin AMD Therapy? AMD Update. http://www.lwwvisioncare.com/emails/amdupdate/index.asp?issue=17

Lim JI.  OCT Imaging with the Optovue System.  Retina Today.  2008

News

Dr. Jenny Lim, professor of ophthalmology received the 2011 Secretariat Award from the AAO

"eOphthalmology" podcast on Diabetic Macular Edema (MP3 file)